Immuno-oncology is the study and development of treatments that take advantage of the body's immune system to fight cancer.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period.
Data collected includes market dynamics, technology outlook, application development, and pricing trends. All of this is fed into a research model, which then produces relevant data for market research. Global market trend analysis is given including historical data, estimates to 2023 and compound annual growth rate (CAGR) forecast to 2028.
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
2023 will be a tough year for much of the global economy, as the ongoing war in Ukraine continues to strain trade, especially in Europe, and the global economy remains reeling from the fallout from the COVID-19 pandemic.
But as China moves ever closer to fully reemerging from three years of government-imposed Covid isolation and reintegrating with the world, economic expectations are high.And with the global economy now facing significant challenges, including energy shortages, slowing growth and high inflation, China's reopening could provide a much-needed and timely boost.
The report researches and analyzes the influence of the Immuno-oncology Drugs industry in the new era of global post-COIVD-19 economy in 2023, and provides in-depth analysis and professional suggestions on the current development.
Market Segment by Product Type
- Immune Checkpoint Inhibitors
- Monoclonal Antibodies
- Cytokine-Based Immunotherapy
- Cancer Vaccines
- CAR-T Cell Therapy
Market Segment by Product Application
- Hospitals
- Pharmacies
- Online Pharmacies
Finally, the report provides detailed profile and data information analysis of leading company.
- Amgen, Inc
- AstraZeneca, Plc
- Bristol-Myers Squibb
- Celgene Corporation
- Eli Lilly and Company
- Merck & Co.
- Hoffmann-La Roche AG
- Johnson & Johnson
- Novartis International AG
- AbbVie, Inc.
- Pfizer Inc.
- Sanofi S.A.
- EMD Serono, Inc.
- Gilead Sciences Inc.
- Prometheus Therapeutics & Diagnostics
- Aduro BioTech
- Galena Biopharma
- Bavarian Nordic
- Celldex Therapeutics
- ImmunoCellular Therapeutics
- Incyte
Insights and Tools:
We follow a comprehensive process to estimate market size. Key industry dynamics, regulatory scenarios, and segmental dynamics are analyzed to understand their impact on demand over the forecast period. Macroeconomic indicators such as prices, income and demographic changes, demand changes, etc. are considered in estimating market size. We also provide an in-depth profile of the key players and discuss their market shares in the global market to derive the market value. In addition, we have an internal database that is regularly updated with key insights and press releases from key stakeholders in the relevant market.
The data is generally gathered in various arrangements such as charts, graphs, infographics, trends, documents and records from various manufacturers and retailers. Our analyst gather, collect, and interpret such data to form significant databases. Our team then works with large data volumes to analyze core developments, evaluate market estimations, and identify trends.
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
Research Objectives
- 1.To study and analyze the global Immuno-oncology Drugs consumption (value) by key regions/countries, product type and application, history data from 2018 to 2022, and forecast to 2028.
- 2.To understand the structure of Immuno-oncology Drugs market by identifying its various subsegments.
- 3.Focuses on the key global Immuno-oncology Drugs manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
- 4.To analyze the Immuno-oncology Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
- 5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
- 6.To project the consumption of Immuno-oncology Drugs submarkets, with respect to key regions (along with their respective key countries).
- 7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
- 8.To strategically profile the key players and comprehensively analyze their growth strategies.
Global Immuno-oncology Drugs Market Research Report 2023, Forecast to 2028
Table of Contents
Global Immuno-oncology Drugs Market Research Report 2023, Forecast to 2028
1 Market Study Overview
1.1 Study Objectives
1.2 Immuno-oncology Drugs Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Immuno-oncology Drugs Segment by Type
2.1.1 Immune Checkpoint Inhibitors
2.1.2 Monoclonal Antibodies
2.1.3 Cytokine-Based Immunotherapy
2.1.4 Cancer Vaccines
2.1.5 CAR-T Cell Therapy
2.2 Market Analysis by Application
2.2.1 Hospitals
2.2.2 Pharmacies
2.2.3 Online Pharmacies
2.3 Global Immuno-oncology Drugs Market Comparison by Regions (2018-2028)
2.3.1 Global Immuno-oncology Drugs Market Size (2018-2028)
2.3.2 North America Immuno-oncology Drugs Status and Prospect (2018-2028)
2.3.3 Europe Immuno-oncology Drugs Status and Prospect (2018-2028)
2.3.4 China Immuno-oncology Drugs Status and Prospect (2018-2028)
2.3.5 Japan Immuno-oncology Drugs Status and Prospect (2018-2028)
2.3.6 Southeast Asia Immuno-oncology Drugs Status and Prospect (2018-2028)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2020 (Covid-19): Immuno-oncology Drugs Industry Impact
2.5.1 Immuno-oncology Drugs Business Impact Assessment - Covid-19
2.5.2 Market Trends and Immuno-oncology Drugs Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Immuno-oncology Drugs Sales and Market Share by Manufacturer (2018-2023)
3.2 Global Immuno-oncology Drugs Revenue and Market Share by Manufacturer (2018-2023)
3.3 Global Immuno-oncology Drugs Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Immuno-oncology Drugs Manufacturer Market Share
3.5 Top 10 Immuno-oncology Drugs Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Immuno-oncology Drugs Market
3.7 Key Manufacturers Immuno-oncology Drugs Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Immuno-oncology Drugs Industry Key Manufacturers
4.1 Amgen, Inc
4.1.1 Compan Detail
4.1.2 Amgen, Inc Immuno-oncology Drugs Product Introduction, Application and Specification
4.1.3 Amgen, Inc 178 Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.1.4 Main Business Overview
4.1.5 Amgen, Inc News
4.2 AstraZeneca, Plc
4.2.1 Compan Detail
4.2.2 AstraZeneca, Plc Immuno-oncology Drugs Product Introduction, Application and Specification
4.2.3 AstraZeneca, Plc Immuno-oncology Drugs Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.2.4 Main Business Overview
4.2.5 Amgen, Inc News
4.3 Bristol-Myers Squibb
4.3.1 Compan Detail
4.3.2 Bristol-Myers Squibb Immuno-oncology Drugs Product Introduction, Application and Specification
4.3.3 Bristol-Myers Squibb Immuno-oncology Drugs Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.3.4 Main Business Overview
4.3.5 Bristol-Myers Squibb News
4.4 Celgene Corporation
4.4.1 Compan Detail
4.4.2 Celgene Corporation Immuno-oncology Drugs Product Introduction, Application and Specification
4.4.3 Celgene Corporation Immuno-oncology Drugs Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.4.4 Main Business Overview
4.4.5 Celgene Corporation News
4.5 Eli Lilly and Company
4.5.1 Compan Detail
4.5.2 Celgene Corporation Immuno-oncology Drugs Product Introduction, Application and Specification
4.5.3 Eli Lilly and Company Immuno-oncology Drugs Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.5.4 Main Business Overview
4.5.5 Eli Lilly and Company News
4.6 Merck & Co.
4.6.1 Compan Detail
4.6.2 Merck & Co. Immuno-oncology Drugs Product Introduction, Application and Specification
4.6.3 Merck & Co. Immuno-oncology Drugs Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.6.4 Main Business Overview
4.6.5 Merck & Co. News
4.7 Hoffmann-La Roche AG
4.7.1 Compan Detail
4.7.2 Hoffmann-La Roche AG Immuno-oncology Drugs Product Introduction, Application and Specification
4.7.3 Hoffmann-La Roche AG Immuno-oncology Drugs Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Johnson & Johnson
4.8.1 Compan Detail
4.8.2 Johnson & Johnson Immuno-oncology Drugs Product Introduction, Application and Specification
4.8.3 Johnson & Johnson Immuno-oncology Drugs Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.8.4 Main Business Overview
4.8.5 Johnson & Johnson News
4.9 Novartis International AG
4.9.1 Compan Detail
4.9.2 Novartis International AG Immuno-oncology Drugs Product Introduction, Application and Specification
4.9.3 Novartis International AG Immuno-oncology Drugs Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.9.4 Main Business Overview
4.9.5 Novartis International AG News
4.10 AbbVie, Inc.
4.10.1 Compan Detail
4.10.2 AbbVie, Inc. Immuno-oncology Drugs Product Introduction, Application and Specification
4.10.3 AbbVie, Inc. Immuno-oncology Drugs Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.10.4 Main Business Overview
4.10.5 AbbVie, Inc. News
4.11 Pfizer Inc.
4.11.1 Compan Detail
4.11.2 Pfizer Inc. Immuno-oncology Drugs Product Introduction, Application and Specification
4.11.3 Pfizer Inc. Immuno-oncology Drugs Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.11.4 Main Business Overview
4.11.5 Pfizer Inc. News
4.12 Sanofi S.A.
4.12.1 Compan Detail
4.12.2 Sanofi S.A. Immuno-oncology Drugs Product Introduction, Application and Specification
4.12.3 Sanofi S.A. Immuno-oncology Drugs Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.12.4 Main Business Overview
4.12.5 Sanofi S.A. News
4.13 EMD Serono, Inc.
4.13.1 Company Details
4.13.2 EMD Serono, Inc. Immuno-oncology Drugs Product Introduction, Application and Specification
4.13.3 EMD Serono, Inc. Immuno-oncology Drugs Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.13.4 Main Business Overview
4.13.5 EMD Serono, Inc. News
4.14 Gilead Sciences Inc.
4.14.1 Compan Detail
4.14.2 Gilead Sciences Inc. Immuno-oncology Drugs Product Introduction, Application and Specification
4.14.3 Gilead Sciences Inc. Immuno-oncology Drugs Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.14.4 Main Business Overview
4.14.5 Gilead Sciences Inc. News
4.15 Prometheus Therapeutics & Diagnostics
4.15.1 Compan Detail
4.15.2 Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Product Introduction, Application and Specification
4.15.3 Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.15.4 Main Business Overview
4.15.5 Prometheus Therapeutics & Diagnostics News
4.16 Aduro BioTech
4.16.1 Compan Detail
4.16.2 Aduro BioTech Immuno-oncology Drugs Product Introduction, Application and Specification
4.16.3 Aduro BioTech Immuno-oncology Drugs Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.16.4 Main Business Overview
4.16.5 Aduro BioTech News
4.17 Galena Biopharma
4.17.1 Compan Detail
4.17.2 Galena Biopharma Immuno-oncology Drugs Product Introduction, Application and Specification
4.17.3 Galena Biopharma Immuno-oncology Drugs Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.17.4 Main Business Overview
4.17.5 Galena Biopharma News
4.18 Bavarian Nordic
4.18.1 Compan Detail
4.18.2 Bavarian Nordic Immuno-oncology Drugs Product Introduction, Application and Specification
4.18.3 Bavarian Nordic Immuno-oncology Drugs Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.18.4 Main Business Overview
4.18.5 Bavarian Nordic News
4.19 Celldex Therapeutics
4.19.1 Compan Detail
4.19.2 Celldex Therapeutics Immuno-oncology Drugs Product Introduction, Application and Specification
4.19.3 Celldex Therapeutics Immuno-oncology Drugs Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.19.4 Main Business Overview
4.19.5 Celldex Therapeutics News
4.20 ImmunoCellular Therapeutics
4.20.1 Compan Detail
4.20.2 ImmunoCellular Therapeutics Immuno-oncology Drugs Product Introduction, Application and Specification
4.20.3 ImmunoCellular Therapeutics Immuno-oncology Drugs Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.20.4 Main Business Overview
4.20.5 ImmunoCellular Therapeutics News
4.21 Incyte
4.21.1 Compan Detail
4.21.2 Incyte Immuno-oncology Drugs Product Introduction, Application and Specification
4.21.3 Incyte Immuno-oncology Drugs Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.21.4 Main Business Overview
4.21.5 Incyte News
5 Global Immuno-oncology Drugs Market Segment by Big Type
5.1 Global Immuno-oncology Drugs Revenue, Sales and Market Share by Big Type (2018-2023)
5.1.1 Global Immuno-oncology Drugs Sales and Market Share by Big Type (2018-2023)
5.1.2 Global Immuno-oncology Drugs Revenue and Market Share by Big Type (2018-2023)
5.2 Immune Checkpoint Inhibitors Sales Growth Rate and Price
5.2.1 Global Immune Checkpoint Inhibitors Sales Growth Rate (2018-2023)
5.2.2 Global Immune Checkpoint Inhibitors Price (2018-2023)
5.3 Monoclonal Antibodies Sales Growth Rate and Price
5.3.1 Global Monoclonal Antibodies Sales Growth Rate (2018-2023)
5.3.2 Global Monoclonal Antibodies Price (2018-2023)
5.4 Cytokine-Based Immunotherapy Sales Growth Rate and Price
5.4.1 Global Cytokine-Based Immunotherapy Sales Growth Rate (2018-2023)
5.4.2 Global Cytokine-Based Immunotherapy Price (2018-2023)
5.5 Cancer Vaccines Sales Growth Rate and Price
5.5.1 Global Cancer Vaccines Sales Growth Rate (2018-2023)
5.5.2 Global Cancer Vaccines Price (2018-2023)
5.6 CAR-T Cell Therapy Sales Growth Rate and Price
5.6.1 Global CAR-T Cell Therapy Sales Growth Rate (2018-2023)
5.6.2 Global CAR-T Cell Therapy Price (2018-2023)
6 Global Immuno-oncology Drugs Market Segment by Big Application
6.1 Global Immuno-oncology Drugs Sales Market Share by Big Application (2018-2023)
6.2 Hospitals Sales Growth Rate (2018-2023)
6.3 Pharmacies Sales Growth Rate (2018-2023)
6.4 Online Pharmacies Sales Growth Rate (2018-2023)
7 Global Immuno-oncology Drugs Forecast
7.1 Global Immuno-oncology Drugs Revenue, Sales and Growth Rate (2023-2028)
7.2 Immuno-oncology Drugs Market Forecast by Regions (2023-2028)
7.2.1 North America Immuno-oncology Drugs Market Forecast (2023-2028)
7.2.2 Europe Immuno-oncology Drugs Market Forecast (2023-2028)
7.2.3 China Immuno-oncology Drugs Market Forecast (2023-2028)
7.2.4 Japan Immuno-oncology Drugs Market Forecast (2023-2028)
7.2.5 Southeast Asia Immuno-oncology Drugs Market Forecast (2023-2028)
7.2.6 Other Regions Immuno-oncology Drugs Market Forecast (2023-2028)
7.3 Immuno-oncology Drugs Market Forecast by Type (2023-2028)
7.3.1 Global Immuno-oncology Drugs Sales Forecast by Type (2023-2028)
7.3.2 Global Immuno-oncology Drugs Market Share Forecast by Type (2023-2028)
7.4 Immuno-oncology Drugs Market Forecast by Application (2023-2028)
7.4.1 Global Immuno-oncology Drugs Sales Forecast by Application (2023-2028)
7.4.2 Global Immuno-oncology Drugs Market Share Forecast by Application (2023-2028)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Immuno-oncology Drugs Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Immuno-oncology Drugs Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Immuno-oncology Drugs
Figure Market Concentration Ratio and Market Maturity Analysis of Immuno-oncology Drugs
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Immuno-oncology Drugs Market Size by Big Type
Figure Global Market Share of Immuno-oncology Drugs by Big Type in 2022
Figure Immune Checkpoint Inhibitors Picture (2018-2023)
Figure Monoclonal Antibodies Picture (2018-2023)
Figure Cytokine-Based Immunotherapy Picture (2018-2023)
Figure Cancer Vaccines Picture (2018-2023)
Global Immuno-oncology Drugs Market Size by Big Application
Table Global Immuno-oncology Drugs Market Size by Application
Figure Global Immuno-oncology Drugs Market Share by Big Application in 2022
Figure Hospitals Picture
Figure Pharmacies Picture
Figure Online Pharmacies Picture
Table Global Immuno-oncology Drugs Comparison by Regions (M USD) ?2018-2028?
Figure Global Immuno-oncology Drugs Market Size (Million US$) (2018-2028)
Figure North America Immuno-oncology Drugs Revenue (Million US$) Growth Rate (2018-2028)
Figure Europe Immuno-oncology Drugs Revenue (Million US$) Growth Rate (2018-2028)
Figure China Immuno-oncology Drugs Revenue (Million US$) Growth Rate (2018-2028)
Figure Japan Immuno-oncology Drugs Revenue (Million US$) Growth Rate (2018-2028)
Figure Southeast Asia Immuno-oncology Drugs Revenue (Million US$) Growth Rate (2018-2028)
Table Business Impact Assessment - Covid-19
Table Market Trends and Immuno-oncology Drugs Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Immuno-oncology Drugs Sales by Manufacturer (2018-2023)
Figure Global Immuno-oncology Drugs Sales Market Share by Manufacturer in 2022
Table Global Immuno-oncology Drugs Revenue by Manufacturer (2018-2023)
Figure Global Immuno-oncology Drugs Revenue Market Share by Manufacturer in 2022
Table Global Immuno-oncology Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Immuno-oncology Drugs Manufacturer (Revenue) Market Share in 2022
Figure Top 10 Immuno-oncology Drugs Manufacturer (Revenue) Market Share in 2022
Table Date of Key Manufacturers Enter into Immuno-oncology Drugs Market
Table Key Manufacturers Immuno-oncology Drugs Product Type
Table Mergers & Acquisitions Planning
Table Amgen, Inc Company Profile
Table Immuno-oncology Drugs Product Introduction, Application and Specification of Amgen, Inc
Table Immuno-oncology Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2018-2023
Table Company One Main Business
Table Company One Recent Development
Table AstraZeneca, Plc Company Profile
Table Immuno-oncology Drugs Product Introduction, Application and Specification of AstraZeneca, Plc
Table Immuno-oncology Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2018-2023
Table AstraZeneca, Plc Recent Development
Table Bristol-Myers Squibb Company Profile
Table Immuno-oncology Drugs Product Introduction, Application and Specification of Bristol-Myers Squibb
Table Immuno-oncology Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2018-2023
Table Bristol-Myers Squibb Main Business
Table Bristol-Myers Squibb Recent Development
Table Celgene Corporation Company Profile
Table Immuno-oncology Drugs Product Introduction, Application and Specification of Celgene Corporation
Table Immuno-oncology Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2018-2023
Table Celgene Corporation Main Business
Table Celgene Corporation Recent Development
Table Celgene Corporation Main Business
Table Celgene Corporation Recent Development
Table Eli Lilly and Company Company Profile
Table Immuno-oncology Drugs Product Introduction, Application and Specification of Eli Lilly and Company
Table Immuno-oncology Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2018-2023
Table Eli Lilly and Company Main Business
Table Eli Lilly and Company Recent Development
Table Merck & Co. Company Profile
Table Immuno-oncology Drugs Product Introduction, Application and Specification of Merck & Co.
Table Immuno-oncology Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2018-2023
Table Merck & Co. Main Business
Table Merck & Co. Recent Development
Table Hoffmann-La Roche AG Company Profile
Table Immuno-oncology Drugs Product Introduction, Application and Specification of Hoffmann-La Roche AG
Table Immuno-oncology Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2018-2023
Table Hoffmann-La Roche AG Main Business
Table Hoffmann-La Roche AG Recent Development
Table Johnson & Johnson Company Profile
Table Immuno-oncology Drugs Product Introduction, Application and Specification of Johnson & Johnson
Table Immuno-oncology Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2018-2023
Table Johnson & Johnson Main Business
Table Johnson & Johnson Recent Development
Table Novartis International AG Company Profile
Table Immuno-oncology Drugs Product Introduction, Application and Specification of Novartis International AG
Table Immuno-oncology Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2018-2023
Table Novartis International AG Main Business
Table Novartis International AG Recent Development
Table AbbVie, Inc. Company Profile
Table Immuno-oncology Drugs Product Introduction, Application and Specification of AbbVie, Inc.
Table Immuno-oncology Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2018-2023
Table AbbVie, Inc. Main Business
Table AbbVie, Inc. Recent Development
Table Pfizer Inc. Company Profile
Table Immuno-oncology Drugs Product Introduction, Application and Specification of Pfizer Inc.
Table Immuno-oncology Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2018-2023
Table Pfizer Inc. Main Business
Table Pfizer Inc. Recent Development
Table Sanofi S.A. Company Profile
Table Immuno-oncology Drugs Product Introduction, Application and Specification of Sanofi S.A.
Table Immuno-oncology Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2018-2023
Table Sanofi S.A. Main Business
Table Sanofi S.A. Recent Development
Table EMD Serono, Inc. Company Profile
Table Immuno-oncology Drugs Product Introduction, Application and Specification of EMD Serono, Inc.
Table Immuno-oncology Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2018-2023
Table EMD Serono, Inc. Main Business
Table EMD Serono, Inc. Recent Development
Table Gilead Sciences Inc. Company Profile
Table Immuno-oncology Drugs Product Introduction, Application and Specification of Gilead Sciences Inc.
Table Immuno-oncology Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2018-2023
Table Gilead Sciences Inc. Main Business
Table Gilead Sciences Inc. Recent Development
Table Aduro BioTech Company Profile
Table Immuno-oncology Drugs Product Introduction, Application and Specification of Aduro BioTech
Table Immuno-oncology Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2018-2023
Table Aduro BioTech Main Business
Table Aduro BioTech Recent Development
Table Galena Biopharma Company Profile
Table Immuno-oncology Drugs Product Introduction, Application and Specification of Galena Biopharma
Table Immuno-oncology Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2018-2023
Table Galena Biopharma Main Business
Table Galena Biopharma Recent Development
Table Bavarian Nordic Company Profile
Table Immuno-oncology Drugs Product Introduction, Application and Specification of Bavarian Nordic
Table Immuno-oncology Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2018-2023
Table Bavarian Nordic Main Business
Table Bavarian Nordic Recent Development
Table Celldex Therapeutics Company Profile
Table Immuno-oncology Drugs Product Introduction, Application and Specification of Celldex Therapeutics
Table Immuno-oncology Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2018-2023
Table Celldex Therapeutics Main Business
Table Celldex Therapeutics Recent Development
Table ImmunoCellular Therapeutics Company Profile
Table Immuno-oncology Drugs Product Introduction, Application and Specification of ImmunoCellular Therapeutics
Table Immuno-oncology Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2018-2023
Table ImmunoCellular Therapeutics Main Business
Table ImmunoCellular Therapeutics Recent Development
Table Incyte Company Profile
Table Immuno-oncology Drugs Product Introduction, Application and Specification of Incyte
Table Immuno-oncology Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2018-2023
Table Incyte Main Business
Table Incyte Recent Development
Figure Global Immuno-oncology Drugs Sales and Growth Rate (2018-2023)
Figure Global Immuno-oncology Drugs Revenue and Growth Rate (2018-2023)
Table Global Immuno-oncology Drugs Sales by Regions (2018-2023)
Figure Global Immuno-oncology Drugs Sales Market Share by Regions in 2022
Table Global Immuno-oncology Drugs Revenue by Regions (2018-2023)
Figure Global Immuno-oncology Drugs Revenue Market Share by Regions in 2022
Figure North America Immuno-oncology Drugs Sales and Growth Rate (2018-2023)
Figure Europe Immuno-oncology Drugs Sales and Growth Rate (2018-2023)
Figure China Immuno-oncology Drugs Sales and Growth Rate (2018-2023)
Figure Japan Immuno-oncology Drugs Sales and Growth Rate (2018-2023)
Figure Southeast Asia Immuno-oncology Drugs Sales and Growth Rate (2018-2023)
Figure Other Regions Immuno-oncology Drugs Sales and Growth Rate (2018-2023)
Table Global Immuno-oncology Drugs Sales by Big Type (2018-2023)
Table Global Immuno-oncology Drugs Sales Market Share by Big Type (2018-2023)
Figure Global Immuno-oncology Drugs Sales Market Share by Big Type in 2020
Table Global Immuno-oncology Drugs Revenue by Big Type (2018-2023)
Table Global Immuno-oncology Drugs Revenue Market Share by Big Type (2018-2023)
Table Global Immuno-oncology Drugs Revenue Market Share by Big Type in 2020
Figure Global Immune Checkpoint Inhibitors Sales Growth Rate (2018-2023)
Figure Global Immune Checkpoint Inhibitors Price (2018-2023)
Figure Global Monoclonal Antibodies Sales Growth Rate (2018-2023)
Figure Global Monoclonal Antibodies Price (2018-2023)
Figure Global Cytokine-Based Immunotherapy Sales Growth Rate (2018-2023)
Figure Global Cytokine-Based Immunotherapy Price (2018-2023)
Figure Global Cancer Vaccines Sales Growth Rate (2018-2023)
Figure Global Cancer Vaccines Price (2018-2023)
Table Global Immuno-oncology Drugs Sales by Big Application (2018-2023)
Table Global Immuno-oncology Drugs Sales Market Share by Big Application (2018-2023)
Figure Global Immuno-oncology Drugs Sales Market Share by Big Application in 2020
Figure Global Hospitals Sales Growth Rate (2018-2023)
Figure Global Pharmacies Sales Growth Rate (2018-2023)
Figure Global Online Pharmacies Sales Growth Rate (2018-2023)
Figure Global Immuno-oncology Drugs Sales and Growth Rate (2023-2028)
Figure Global Immuno-oncology Drugs Revenue and Growth Rate (2023-2028)
Table Global Immuno-oncology Drugs Sales Forecast by Regions (2023-2028)
Table Global Immuno-oncology Drugs Market Share Forecast by Regions (2023-2028)
Figure North America Sales Immuno-oncology Drugs Market Forecast (2023-2028)
Figure Europe Sales Immuno-oncology Drugs Market Forecast (2023-2028)
Figure China Sales Immuno-oncology Drugs Market Forecast (2023-2028)
Figure Japan Sales Immuno-oncology Drugs Market Forecast (2023-2028)
Figure Southeast Asia Sales Immuno-oncology Drugs Market Forecast (2023-2028)
Figure Other Regions Sales Immuno-oncology Drugs Market Forecast (2023-2028)
Table Global Immuno-oncology Drugs Sales Forecast by Type (2023-2028)
Table Global Immuno-oncology Drugs Market Share Forecast by Type (2023-2028)
Table Global Immuno-oncology Drugs Sales Forecast by Application (2023-2028)
Table Global Immuno-oncology Drugs Market Share Forecast by Application (2023-2028)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Immuno-oncology Drugs
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Immuno-oncology Drugs Sales (K Units) Growth Rate Forecast (2022-2026)
Figure North America Immuno-oncology Drugs Revenue (Million US$) Growth Rate Forecast (2022-2026)
Figure Europe Immuno-oncology Drugs Sales (K Units) Growth Rate Forecast (2022-2026)
Figure Europe Immuno-oncology Drugs Revenue (Million US$) Growth Rate Forecast (2022-2026)
Figure Japan Immuno-oncology Drugs Production (K Units) Growth Rate Forecast (2022-2026)
Figure Japan Immuno-oncology Drugs Revenue (Million US$) Growth Rate Forecast (2022-2026)
Figure China Immuno-oncology Drugs Production (K Units) Growth Rate Forecast (2022-2026)
Figure China Immuno-oncology Drugs Revenue (Million US$) Growth Rate Forecast (2022-2026)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Global Antioxidant Vitamins Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 100
The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
Global Clavulanate Potassium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 86
The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030.
North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
Global Amoxicillin Sodium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 84
The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030.
North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
Global Melatonin Supplements Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 106
The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 93
The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
Global Sleeping Pills Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 94
The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
Global Zinc Oral Drops Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
Global Zinc Drops Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
Global Anti-Infectives Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 78
The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
